(FRAG (NP (NN Objective)) (: :) (S (NP (NN Anemia)) (VP (VBZ is) (NP (NP (DT a) (JJ frequent) (NN comorbidity)) (PP (IN in) (NP (NP (NN hemodialysis) (NNS patients)) (SBAR (WHNP (WDT that)) (S (VP (MD can) (VP (VB be) (ADVP (RB successfully)) (VP (VBN treated) (PP (IN by) (NP (ADJP (VBG administering)) (ADJP (NN erythropoiesis) (HYPH -) (VBG stimulating)) (NNS agents))) (PRN (-LRB- -LRB-) (NP (NNS ESAs)) (-RRB- -RRB-)))))))))))) (. .))
(S (NP (NNS ESAs) (NN dosing)) (VP (VBZ is) (ADVP (RB currently)) (VP (VBN based) (PP (IN on) (NP (NP (JJ clinical) (NNS protocols)) (SBAR (WHNP (WDT that)) (S (ADVP (RB often)) (VP (VBP do) (RB not) (VP (VB account) (PP (IN for) (NP (NP (DT the) (JJ high) (ADJP (AFX inter) (HYPH -) (CC and) (JJ intra-individual)) (NN variability)) (PP (IN in) (NP (NP (DT the) (NN patient) (POS 's)) (NN response))))))))))))) (. .))
(S (PP (IN As) (NP (DT a) (NN result))) (, ,) (NP (NP (DT the) (NN hemoglobin) (NN level)) (PP (IN of) (NP (DT some) (NNS patients)))) (VP (VBZ oscillates) (PP (IN around) (NP (NP (DT the) (NN target) (NN range)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (VP (VBN associated) (PP (IN with) (NP (NP (JJ multiple) (NNS risks)) (CC and) (NP (NN side) (HYPH -) (NNS effects))))))))))) (. .))
(S (NP (DT This) (NN work)) (VP (VBZ proposes) (NP (NP (DT a) (NN methodology)) (VP (VBN based) (PP (IN on) (NP (NN reinforcement) (NN learning) (PRN (-LRB- -LRB-) (NP (NN RL)) (-RRB- -RRB-)))) (S (VP (TO to) (VP (VB optimize) (NP (NN ESA) (NN therapy)))))))) (. .))
(FRAG (NP (NNS Methods)) (: :) (S (NP (NN RL)) (VP (VBZ is) (NP (NP (DT a) (ADJP (NN data) (HYPH -) (VBN driven)) (NN approach)) (PP (IN for) (S (VP (VBG solving) (NP (NP (JJ sequential) (ADJP (NN decision) (HYPH -) (VBG making)) (NNS problems)) (SBAR (WHNP (WDT that)) (S (VP (VBP are) (VP (VBN formulated) (PP (IN as) (NP (NNP Markov) (NN decision) (NNS processes))) (PRN (-LRB- -LRB-) (NP (NNS MDPs)) (-RRB- -RRB-))))))))))))) (. .))
(S (NP (NP (NNP Computing)) (NP (NP (JJ optimal) (NN drug) (NN administration) (NNS strategies)) (PP (IN for) (NP (JJ chronic) (NNS diseases))))) (VP (VBZ is) (NP (NP (DT a) (JJ sequential) (ADJP (NN decision) (HYPH -) (VBG making)) (NN problem)) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (DT the) (NN goal)) (VP (VBZ is) (S (VP (TO to) (VP (VB find) (NP (NP (DT the) (JJS best) (NN sequence)) (PP (IN of) (NP (NN drug) (NNS doses)))))))))))) (. .))
(S (NP (NNS MDPs)) (VP (VBP are) (ADJP (RB particularly) (JJ suitable) (PP (IN for) (S (VP (VBG modeling) (NP (DT these) (NNS problems)) (PP (IN due) (IN to) (NP (PRP$ their) (NN ability) (S (VP (TO to) (VP (VB capture) (NP (NP (DT the) (NN uncertainty)) (VP (VBN associated) (PP (IN with) (NP (NP (NP (DT the) (NN outcome)) (PP (IN of) (NP (DT the) (NN treatment)))) (CC and) (NP (NP (DT the) (JJ stochastic) (NN nature)) (PP (IN of) (NP (DT the) (JJ underlying) (NN process)))))))))))))))))) (. .))
(S (NP (NP (DT The) (NN RL) (NN algorithm)) (VP (VBN employed) (PP (IN in) (NP (DT the) (VBN proposed) (NN methodology))))) (VP (VBZ is) (NP (NP (VBN fitted) (NN Q) (NN iteration)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ stands) (PRT (RP out)) (PP (IN for) (NP (PRP$ its) (NN ability) (S (VP (TO to) (VP (VB make) (NP (NP (DT an) (JJ efficient) (NN use)) (PP (IN of) (NP (NNS data)))))))))))))) (. .))
(S (NP (NP (NNS Results)) (: :) (NP (NP (DT The) (NNS experiments)) (VP (VBN reported) (ADVP (RB here))))) (VP (VBP are) (VP (VBN based) (PP (IN on) (NP (NP (DT a) (JJ computational) (NN model)) (SBAR (WHNP (WDT that)) (S (VP (VBZ describes) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NP (NNS ESAs)) (PP (IN on) (NP (DT the) (NN hemoglobin) (NN level))))))))))))) (. .))
(S (NP (NP (DT The) (NN performance)) (PP (IN of) (NP (DT the) (JJ proposed) (NN method)))) (VP (VBZ is) (VP (VBN evaluated) (CC and) (VBN compared) (PP (PP (IN with) (NP (DT the) (ADJP (NN well) (HYPH -) (VBN known)) (NML (NN Q) (HYPH -) (NN learning)) (NN algorithm))) (CC and) (PP (IN with) (NP (DT a) (JJ standard) (NN protocol)))))) (. .))
(S (NP (NNP Simulation) (NNS results)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (NN performance)) (PP (IN of) (NP (NN Q) (HYPH -) (NN learning)))) (VP (VBZ is) (ADJP (ADJP (RB substantially) (JJR lower)) (PP (IN than) (NP (NP (NN FQI)) (CC and) (NP (DT the) (NN protocol))))))))) (. .))
(FRAG (NP (NN Conclusion)) (: :) (S (SBAR (IN Although) (S (NP (JJ prospective) (NN validation)) (VP (VBZ is) (VP (VBN required))))) (, ,) (NP (JJ promising) (NNS results)) (VP (VBP demonstrate) (NP (NP (DT the) (NN potential)) (PP (IN of) (NP (NN RL)))) (S (VP (TO to) (VP (VB become) (NP (DT an) (NN alternative)) (PP (IN to) (NP (JJ current) (NNS protocols)))))))) (. .))
